Politician trade (House)

Johnson & Johnson (JNJ)Rep. Scott Scott Franklin (FL18) disclosed a sale $15K–$50K

Rep. Scott Scott Franklin (FL18) disclosed a sale of Johnson & Johnson in the $15K–$50K range.

$15,001–$50,000
Reported range · official band, not an exact amount
28 days
Disclosure lag
Traded
Jun 16, 2025
Disclosed
Jul 14, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 15, 2023CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  2. Aug 7, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  3. Sep 26, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  4. Oct 29, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  5. Mar 19, 2025CongressDisclosed sale of JNJ — reported range $15,001 - $50,000
  6. Mar 24, 2025CongressDisclosed sale of JNJ — reported range $100,001 - $250,000
  7. Apr 1, 2025CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
  8. Apr 8, 2025CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
  9. Apr 9, 2025CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
  10. Apr 21, 2025CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
  11. Apr 29, 2025Congress · 1 personMembers of Congress: 2 sales
  12. May 5, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  13. May 12, 2025CongressDisclosed sale of JNJ — reported range $50,001 - $100,000
  14. May 30, 2025CongressDisclosed purchase of JNJ — reported range $15,001 - $50,000
  15. Jun 10, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  16. Jun 12, 2025CongressDisclosed sale of JNJ — reported range $15,001 - $50,000
  17. Jun 16, 2025 · this disclosureCongressDisclosed sale of JNJ — reported range $15,001 - $50,000

What came next

  1. Jun 17, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  2. Jun 24, 2025CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
  3. Jul 17, 2025InsiderOfficer sold ~$3.13M of JNJ shares in the open market
  4. Jul 31, 2025CongressDisclosed partial sale of JNJ — reported range $15,001 - $50,000
  5. Aug 4, 2025Congress · 1 personMembers of Congress: 2 purchases
  6. Aug 14, 2025FDAFDA drug approval: Rybrevant
  7. Aug 14, 2025FDAFDA drug approval: Lazcluze
  8. Aug 14, 2025CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
  9. Aug 15, 2025FDARecall: STRATAFIX Spiral PDS Plus Bidirectional Knotless Tissue Control Device, SFX SPI PDS+ BI VIO 14X14IN(36X36CM) USP1(M4) D/A MO-4. Product Code: SXPP2B400-11.
  10. Aug 15, 2025InsiderCFO sold ~$2.98M of JNJ shares in the open market
  11. Aug 19, 2025CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
  12. Aug 20, 2025FDARecall: Automated Impella Controller (AIC) with the below brands and product codes. Used with heart assist pump. 1. Impella Controller, Packaged, US; Product Code: 004…
  13. Aug 22, 2025FDAFDA device clearance: CARTO™ 3 EP Navigation System V8.1
  14. Aug 22, 2025InsiderCEO sold ~$22.5M of JNJ shares in the open market
  15. Sep 4, 2025Insider · 4 days before an 8-KOfficer sold ~$10M of JNJ shares in the open market
  16. Sep 8, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On September 8, 2025, Johnson & Johnson (the Company) announced that John Morikis was elected to the Board of Directors. The Board has determined that Mr. Morikis satisfies the applicable independence requirements of the NYSE Listed Company Manual.”
  17. Sep 9, 2025FDAFDA drug approval: Inlexzo
  18. Sep 11, 2025FDARecall: ECHELON LINEAR Cutters Reload 80 mm Blue, intended for transection, resection, and/or creation of anastomoses, Product Number GLC80
  19. Sep 16, 2025FDARecall: Automated Impella Controller (AIC) labeled as the following with corresponding Product Codes: 1. AIC w/Impella Connect for ECP, Product Code: 1000432. 2. Dbl o…
  20. Sep 19, 2025FDAFDA drug approval: Tremfya
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Johnson & Johnson

For Johnson & Johnson, OQRO holds 15 insider filings (SEC Form 4 or Form 144), 8 Congress trade reports, 167 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its JNJ page.

Other recent filings by Rep. Scott Scott Franklin (FL18)

The full history of Rep. Scott Scott Franklin (FL18) is on the profile page.

How this filing works

Other disclosures at Johnson & Johnson

Everything OQRO holds on this company is on its JNJ page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data